Cargando…

Parathyroid Apoplexy Following Cinacalcet Treatment in Primary Hyperparathyroidism

Cinacalcet, a calcimimetic drug, is considered a safe and valid option for the treatment of hypercalcemia in patients with primary hyperparathyroidism who are unable to undergo parathyroidectomy. Hypocalcemia and gastrointestinal adverse reactions are the main side effects reported in patients treat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Di Dalmazi, Giulia, Giuliani, Cesidio, Napolitano, Giorgio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6308315/ https://www.ncbi.nlm.nih.gov/pubmed/30622514 http://dx.doi.org/10.3389/fendo.2018.00777

Ejemplares similares

Non-Conventional Clinical Uses of TSH Receptor Antibodies: The Case of Chronic Autoimmune Thyroiditis
por: Napolitano, Giorgio, et al.
Publicado: (2021)

Thyroid Autoimmunity in Female Infertility and Assisted Reproductive Technology Outcome
por: Bucci, Ines, et al.
Publicado: (2022)

A Detailed Analysis of the Factors Influencing Neonatal TSH: Results From a 6-Year Congenital Hypothyroidism Screening Program
por: Di Dalmazi, Giulia, et al.
Publicado: (2020)

Cinacalcet Treatment of Primary Hyperparathyroidism
por: Rothe, H. M., et al.
Publicado: (2011)

The Role of the Transcription Factor Nuclear Factor-kappa B in Thyroid Autoimmunity and Cancer
por: Giuliani, Cesidio, et al.
Publicado: (2018)

Thyroid-Stimulating Hormone Receptor Antibodies in Pregnancy: Clinical Relevance
por: Bucci, Ines, et al.
Publicado: (2017)

Cinacalcet use in secondary hyperparathyroidism: a machine learning-based systematic review
por: Li, Xiaosong, et al.
Publicado: (2023)

Successful cinacalcet treatment of refractory secondary hyperparathyroidism due to multiple lung parathyroid adenomas
por: Sugi, Orie, et al.
Publicado: (2010)

Parathyroid apoplexy, the explanation of spontaneous remission of primary hyperparathyroidism: a case report
por: Efremidou, Eleni I, et al.
Publicado: (2009)

SAT-349 Cinacalcet Resistant Tertiary Hyperparathyroidism with One Large Parathyroid Gland
por: Chaker, Bayan, et al.
Publicado: (2020)

Bioassays for TSH Receptor Autoantibodies, from FRTL-5 Cells to TSH Receptor–LH/CG Receptor Chimeras: The Contribution of Leonard D. Kohn
por: Giuliani, Cesidio, et al.
Publicado: (2016)

Long-term treatment with cinacalcet and conventional therapy reduces parathyroid hyperplasia in severe secondary hyperparathyroidism
por: Meola, Mario, et al.
Publicado: (2009)

Parathyroid adenoma apoplexy as a temporary solution of primary hyperparathyroidism: a case report
por: Pereira, Francisco A, et al.
Publicado: (2007)

Editorial: The Legacy of Dr. Leonard D. Kohn to Thyroid Pathophysiology
por: Giuliani, Cesidio, et al.
Publicado: (2022)

Cinacalcet is effective in the treatment of hyperparathyroidism secondary to malignant transformation of autotransplanted parathyroid tissue. A case report
por: Dattolo, Pietro, et al.
Publicado: (2010)

Primary hyperparathyroidism in pregnancy treated with cinacalcet: a case report and review of the literature
por: Vera, Lara, et al.
Publicado: (2016)

Cinacalcet and primary hyperparathyroidism: systematic review and meta regression
por: Ng, Cheng Han, et al.
Publicado: (2020)

Cognitive impairment reversed by cinacalcet administration in primary hyperparathyroidism
por: Timmons, J. G., et al.
Publicado: (2021)

Hormonal Regulation of the MHC Class I Gene in Thyroid Cells: Role of the Promoter “Tissue-Specific” Region
por: Giuliani, Cesidio, et al.
Publicado: (2021)

Three Therapeutic Strategies: Cinacalcet, Paricalcitol or Both in Secondary Hyperparathyroidism Treatment in Hemodialysed Patients During 1-Year Observational Study—A Comparison
por: Zawierucha, Jacek, et al.
Publicado: (2019)

Association between long-term efficacy of cinacalcet and parathyroid gland volume in haemodialysis patients with secondary hyperparathyroidism
por: Tanaka, Motoko, et al.
Publicado: (2008)

Cinacalcet: A Viable Therapeutic Option for Primary Hyperparathyroidism in the Elderly
por: Abusahmin, Hussam, et al.
Publicado: (2018)

Ectopic Pleural Parathyroid Adenoma Causing Recurrent Primary Hyperparathyroidism
por: Kaur, Jasleen, et al.
Publicado: (2022)

Successful Early Treatment of Severe Neonatal Hyperparathyroidism With Cinacalcet
por: Thakkar, Keya, et al.
Publicado: (2021)

Persistent hyperparathyroidism secondary to ectopic parathyroid adenoma in lung: Case report
por: Valizadeh, Majid, et al.
Publicado: (2022)

Failed Switching off in the MIBI-Parathyroid Scintigraphy in a Dialyzed Patient with Secondary Hyperparathyroidism Responsive to Cinacalcet Therapy
por: Bolasco, Piergiorgio, et al.
Publicado: (2010)

Primary Hyperparathyroidism Secondary to a Sestamibi-Negative Cystic Parathyroid Adenoma
por: Win, George M, et al.
Publicado: (2021)

Clinical Use of Cinacalcet in MEN1 Hyperparathyroidism
por: Moyes, V. J., et al.
Publicado: (2010)

A single-centre retrospective analysis of cinacalcet therapy in primary hyperparathyroidism
por: Bell, Daniel, et al.
Publicado: (2021)

Successful treatment of inoperable recurrent secondary hyperparathyroidism with cinacalcet HCl
por: Eriguchi, Rieko, et al.
Publicado: (2008)

Successful treatment of neonatal severe hyperparathyroidism with cinacalcet in two patients
por: Fisher, Marisa M, et al.
Publicado: (2015)

The conundrum of parathyroidectomy vs cinacalcet for treatment of post-transplant hyperparathyroidism
por: Patel, Rima, et al.
Publicado: (2020)

Parathyroidectomy Versus Cinacalcet for the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients
por: Alvarado, Luis, et al.
Publicado: (2022)

Serum phosphorus reduction in dialysis patients treated with cinacalcet for secondary hyperparathyroidism results mainly from parathyroid hormone reduction
por: Zitt, Emanuel, et al.
Publicado: (2013)

Pharmacogenetic analysis of cinacalcet response in secondary hyperparathyroidism patients
por: Jeong, Sohyun, et al.
Publicado: (2016)

Cinacalcet-Associated Resolution of Primary Hyperparathyroidism in a Patient With Normal Kidney Function
por: Nguyen, Son, et al.
Publicado: (2020)

Use of Parathyroid Function Index and Wisconsin Index to Differentiate Primary Hyperparathyroidism From Secondary Hyperparathyroidism: A Case-Control Study
por: Özkan, Murat Bulut, et al.
Publicado: (2022)

An Atypical Presentation of Primary Hyperparathyroidism in an Adolescent: A Case Report of Hypercalcaemia and Neuropsychiatric Symptoms Due to a Mediastinal Parathyroid Adenoma
por: Minelli, Roberta, et al.
Publicado: (2020)

Partial response to cinacalcet treatment in a patient with secondary hyperparathyroidism undergoing hemodialysis: a case report
por: Conzo, Giovanni, et al.
Publicado: (2012)

Cholecalciferol Additively Reduces Serum Parathyroid Hormone Levels in Severe Secondary Hyperparathyroidism Treated with Calcitriol and Cinacalcet among Hemodialysis Patients
por: Zheng, Cai-Mei, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2qtoh2tgercopfhcjf0h04i767